Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DS-01 by Seed Health for Irritable Bowel Syndrome: Likelihood of Approval
DS-01 is under clinical development by Seed Health and currently in Phase II for Irritable Bowel Syndrome. According to GlobalData,...